[1]
|
van Ballegooijen, A.J., Kestenbaum, B., Sachs, M.C., et al. (2014) Association of 25-Hydroxyvitamin D and Parathyroid Hormone with Incident Hypertension: MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology, 63, 1214-1222. https://doi.org/10.1016/j.jacc.2014.01.012
|
[2]
|
Kestenbaum, B., Katz, R., de Boer, I., et al. (2011) Vitamin D, Parathyroid Hormone, and Cardiovascular Events among Older Adults. Journal of the American College of Cardiology, 58, 1433-1441.
https://doi.org/10.1016/j.jacc.2011.03.069
|
[3]
|
Arase, H., Yamada, S., Tanaka, S., et al. (2020) Association be-tween Plasma Intact Parathyroid Hormone Levels and the Prevalence of Atrial Fibrillation in Patients with Chronic Kid-ney Disease—The Fukuoka Kidney Disease Registry Study. Circulation Journal, 84, 1105-1111. https://doi.org/10.1253/circj.CJ-19-1201
|
[4]
|
Li, M.Y., Cheng, J.F., Zhao, J., et al. (2021) Relationship between Intact Parathyroid Hormone and All-Cause Death, Cardiovascular Events, and Ectopic Calcification in Patients with Dia-betic Kidney Disease: A Retrospective Study. Diabetes Research and Clinical Practice, 177, Article ID: 108926. https://doi.org/10.1016/j.diabres.2021.108926
|
[5]
|
Pilz, S., Tomaschitz, A., Drechsler, C., et al. (2010) Parathyroid Hormone Level Is Associated with Mortality and Cardiovascular Events in Patients Undergoing Coronary Angiography. European Heart Journal, 31, 1591-1598.
|
[6]
|
李南方, 骆秦. 高血压患者中原发性醛固酮增多症检出, 诊断和治疗的指导意见[J]. 中华高血压杂志, 2021, 29(6): 508-518.
|
[7]
|
Dick, S.M., Queiroz, M., Bárbara, L.B., et al. (2018) Update Indiagnosis and Management of Primary Aldosteronism. Clinical Chemistry and Laboratory Medicine, 56, 360-372.
|
[8]
|
Calhoun, D.A. (2019) Is There an Epidemic of Primary Aldosteronism? (Pro). Journal of Human Hyper-tension. 16, 151-152. https://doi.org/10.1038/sj.jhh.1001319
|
[9]
|
Xu, Z., Yang, J., Hu, J., et al. (2020) Primary Aldosteronism in Patients in China with Recently Detected Hypertension. Journal of the American College of Cardiology, 75, 1913-1922. https://doi.org/10.1016/j.jacc.2020.02.052
|
[10]
|
Vasan, R.S., Evans, J.C., Larson, M.G., et al. (2004) Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons. The New England Journal of Medicine, 351, 33-41. https://doi.org/10.1056/NEJMoa033263
|
[11]
|
Wu, X.Y., Yu, J. and Tian, H.M. (2019) Car-diovascular Risk in Primary Aldosteronism: A Systematic Review and Meta-Analysis. Medicine, 98, e15985. https://doi.org/10.1097/MD.0000000000015985
|
[12]
|
Monticone, S., D’Ascenzo, F., Moretti, C., et al. (2018) Car-diovascular Events and Target Organ Damage in Primary Aldosteronism Compared with Essential Hypertension: A Sys-tematic Review and Meta-Analysis. The Lancet Diabetes and Endocrinology, 6, 41-50. https://doi.org/10.1016/S2213-8587(17)30319-4
|
[13]
|
Amar, L., Baguet, J.P., Bardet, S., et al. (2016) SFE/SFHTA/AFCE Primary Aldosteronism Consensus: Introduction and Handbook. Annales d’Endocrinologie, 77, 179-186. https://doi.org/10.1016/j.ando.2016.05.001
|
[14]
|
Kluwe, B., Pohlman, N., Kesireddy, V., et al. (2023) The Role of Aldosterone and Ideal Cardiovascular Health in incident Cardiovascular Disease: The Jackson Heart Study. American Journal of Preventive Cardiology, 14, Article ID: 100494. https://doi.org/10.1016/j.ajpc.2023.100494
|
[15]
|
Ungvari, Z., Tarantini, S., Kiss, T., et al. (2018) Endothelial Dys-function and Angiogenesis Impairment in the Ageing Vasculature. Nature Reviews Cardiology, 15, 555-565. https://doi.org/10.1038/s41569-018-0030-z
|
[16]
|
Nagata, D., Takahashi, M., Sawai, K., et al. (2006) Molecular Mechanism of the Inhibitory Effect of Aldosterone on Endothelial NO Synthase Activity. Hypertension, 48, 165-171. https://doi.org/10.1161/01.HYP.0000226054.53527.bb
|
[17]
|
McGraw, A.P., Bagley, J., Chen, W.S., et al. (2013) Aldosterone Increases Early Atherosclerosis and Promotes Plaque Inflammation through a Placental Growth Fac-tor-Dependent Mechanism. Journal of the American Heart Association, 2, e000018. https://doi.org/10.1161/JAHA.112.000018
|
[18]
|
Bruder-Nascimento, T., Ferreira, N.S., Zanotto, C.Z., et al. (2016) NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage. Circulation, 134, 1866-1880. https://doi.org/10.1161/CIRCULATIONAHA.116.024369
|
[19]
|
Usher, M.G., Duan, S.Z., Ivaschenko, C.Y., et al. (2010) Myeloid Mineralocorticoid Receptor Controls Macrophage Polarization and Cardiovascular Hypertrophy and Remodeling in Mice. Journal of Clinical Investigation, 120, 3350-3364.
https://doi.org/10.1172/JCI41080
|
[20]
|
Demirtas, D., Sumbul, H.E., Bulut, A., et al. (2020) Tp-e interval, Tp-e/QT and Tp-e/QTc Ratio in Hypertensive Patients with Primary Aldosteronism. Clinical and Experimental Hypertension, 42, 93-98.
https://doi.org/10.1080/10641963.2019.1632341
|
[21]
|
Ivanes, F., Susen, S., Mouquet, F., et al. (2012) Aldosterone, Mortality, and Acute Ischaemic Events in Coronary Artery Disease Patients Outside the Setting of Acute Myocardial In-farction or Heart Failure. European Heart Journal, 33, 191-202. https://doi.org/10.1093/eurheartj/ehr176
|
[22]
|
Beygui, F., Collet, J.P., Benoliel, J.J., et al. (2006) High Plasma Al-dosterone Levels on Admission Are Associated with Death in Patients Presenting with Acute ST-Elevation Myocardial Infarction. Circulation, 114, 2604-2610.
https://doi.org/10.1161/CIRCULATIONAHA.106.634626
|
[23]
|
Potts, J.T. (2005) Parathyroid Hormone: Past and Present. Journal of Endocrinology, 187, 311-325.
https://doi.org/10.1677/joe.1.06057
|
[24]
|
Fitzpatrick, L.A., Bilezikian, J.P. and Silverberg, S.J. (2008) Parathyroid Hormone and the Cardiovascular System. Current Osteoporosis Reports, 6, 77-83. https://doi.org/10.1007/s11914-008-0014-8
|
[25]
|
van Ballegooijen, A.J., Kestenbaum, B., Sachs, M.C., et al. (2004) Association of 25-Hydroxyvitamin D and Parathyroid Hormone with Incident Hypertension: MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology, 63, 1214-1222. https://doi.org/10.1016/j.jacc.2014.01.012
|
[26]
|
Kestenbaum, B., Katz, R., de Boer, I., et al. (2011) Vitamin D, Par-athyroid Hormone, and Cardiovascular Events among Older Adults. Journal of the American College of Cardiology, 58, 1433-1441.
https://doi.org/10.1016/j.jacc.2011.03.069
|
[27]
|
Chen, W.R., Chen, Y.D., Shi, Y., et al. (2015) Vitamin D, Para-thyroid Hormone and Risk Factors for Coronary Artery Disease in an Elderly Chinese Population. Journal of Cardio-vascular Medicine, 16, 59-68.
https://doi.org/10.2459/JCM.0000000000000094
|
[28]
|
Linhartová, K., Veselka, J., Sterbáková, G., et al. (2008) Parathyroid Hormone and Vitamin D Levels Are Independently Associated with Calcific Aortic Stenosis. Circulation Journal, 72, 245-250. https://doi.org/10.1253/circj.72.245
|
[29]
|
Hagström, E., Ahlström, T., Ärnlöv, J., et al. (2015) Parathyroid Hormone and Calcium Are Independently Associated with Subclinical Vascular Disease in a Communi-ty-Based Cohort. Atherosclerosis, 238, 420-426.
https://doi.org/10.1016/j.atherosclerosis.2014.12.027
|
[30]
|
Bosworth, C., Sachs, M.C., Duprez, D., et al. (2013) Parathyroid Hormone and Arterial Dysfunction in the Multi-Ethnic Study of Atherosclerosis. Clinical Endocrinology, 79, 429-436. https://doi.org/10.1111/cen.12163
|
[31]
|
Rienstra, M., Lubitz, S.A., Zhang, M.L., et al. (2011) Elevation of Parathyroid Hormone Levels in Atrial Fibrillation. Journal of the American College of Cardiology, 57, 2542-2543. https://doi.org/10.1016/j.jacc.2011.01.041
|
[32]
|
Çelik, G., Doğan, A., Dener, Ş., et al. (2017) Parathyroid Hormone Levels in the Prediction of Ischemic Stroke Risk. Disease Markers, 2017, Article ID: 4343171. https://doi.org/10.1155/2017/4343171
|
[33]
|
Hagström, E., Hellman, P., Larsson, T.E., et al. (2009) Plasma Para-thyroid Hormone and the Risk of Cardiovascular Mortality in the Community. Circulation, 119, 2765-2771. https://doi.org/10.1161/CIRCULATIONAHA.108.808733
|
[34]
|
Deo, R., Katz, R., Shlipak, M.G., et al. (2011) Vitamin D, Parathyroid Hormone, and Sudden Cardiac Death: Results from the Cardiovascular Health Study. Hyperten-sion, 58, 1021-1028.
https://doi.org/10.1161/HYPERTENSIONAHA.111.179135
|
[35]
|
van Ballegooijen, A.J., Reinders, I., Visser, M. and Brouwer, I.A. (2013) Parathyroid Hormone and Cardiovascular Disease Events: A Systematic Review and Me-ta-Analysis of Prospective Studies. American Heart Journal, 165, 655-664.e5.
https://doi.org/10.1016/j.ahj.2013.02.014
|
[36]
|
Tastan, I., Schreckenberg, R., Mufti, S., et al. (2009) Parathyroid Hormone Improves Contractile Performance of Adult Rat Ventricular Cardiomyocytes at Low Concentrations in a Non-Acute Way. Cardiovascular Research, 82, 77-83.
https://doi.org/10.1093/cvr/cvp027
|
[37]
|
Bogin, E., Massry, S.G. and Harary, I. (1981) Effect of Parathyroid Hor-mone on Rat Heart Cells. Journal of Clinical Investigation, 67, 1215-1227. https://doi.org/10.1172/JCI110137
|
[38]
|
Schlüter, K.D., Weber, M. and Piper, H.M. (1995) Parathyroid Hormone Induces Protein Kinase C But Not Adenylate Cyclase in Adult Cardiomyocytes and Regulates Cyclic AMP Levels via Protein Kinase C-Dependent Phosphodiesterase Activity. Biochemical Journal, 310, 439-444. https://doi.org/10.1042/bj3100439
|
[39]
|
Tomaschitz, A., Ritz, E., Pieske, B., et al. (2014) Aldosterone and Parathy-roid Hormone Interactions as Mediators of Metabolic and Cardiovascular Disease. Metabolism, 63, 20-31. https://doi.org/10.1016/j.metabol.2013.08.016
|
[40]
|
Milicic Stanic, B., Ilincic, B., Zeravica, R., et al. (2022) The Importance of Correlation between Aldosterone and Parathyroid Hormone in Patients with Primary Hyperparathyroidism. International Journal of Endocrinology, 2022, Article ID: 3804899. https://doi.org/10.1155/2022/3804899
|
[41]
|
Wang, A.N., Wang, Y.H., Liu, H.Z., et al. (2022) Bone and Mineral Metabolism in Patients with Primary Aldosteronism: A Systematic Review and Meta-Analysis. Frontiers in Endocrinol-ogy, 13, Article 1027841.
https://doi.org/10.3389/fendo.2022.1027841
|
[42]
|
Loh, H.H., Yee, A. and Loh, H.S. (2019) Bone Health among Patients with Primary Aldosteronism: A Systematic Review and Meta-Analysis. Minerva Endocrinology, 44, 387-396. https://doi.org/10.23736/S0391-1977.18.02867-5
|
[43]
|
Liu, Y.J., Yang, G.Q., Pei, J.T., et al. (2021) [Value of Se-rum Parathyroid Hormone in the Diagnosis of Primary Aldosteronism]. Chinese Medical Journal, 101, 2674-2680.
|
[44]
|
Brown, J., de Boer, I.H., Robinson-Cohen, C., et al. (2015) Aldosterone, Parathyroid Hormone, and the Use of Renin-Angiotensin-Aldosterone System Inhibitors: The Multi-Ethnic Study of Atherosclerosis. The Journal of Clinical Endocrinology & Metabolism, 100, 490-499. https://doi.org/10.1210/jc.2014-3949
|
[45]
|
Evelyn, F., Anke, H., Rainer, R., et al. (2014) A High Aldosterone to Renin Ratio Is Associated with High Serum Parathyroid Hormone Concentrations in the General Population. The Journal of Clinical Endocrinology & Metabolism, 99, 965-971.
|
[46]
|
Pilz, S., Kienreich, K., Drechsler, C., et al. (2012) Hyperparathyroidism in Patients with Primary Aldosteronism: Cross-Sectional and Interventional Data from the GECOH Study. The Journal of Clinical Endocrinology & Metabolism, 97, E75-E79. https://doi.org/10.1210/jc.2011-2183
|
[47]
|
Kovács, L.,Góth, M.I., Szabolcs, I., et al. (1998) The Ef-fect of Surgical Treatment on Secondary Hyperaldosteronism and Relative Hyperinsulinemia in Primary Hyperparathy-roidism. European Journal of Endocrinology, 138, 543-547.
https://doi.org/10.1530/eje.0.1380543
|
[48]
|
Tomaschitz, A., Pilz, S., Rus-Machan, J., et al. (2015) Interrelated Al-dosterone and Parathyroid Hormone Mutually Modify Cardiovascular Mortality Risk. International Journal of Cardiol-ogy, 184, 710-716.
https://doi.org/10.1016/j.ijcard.2015.03.062
|
[49]
|
Lenzini, L., Prisco, S., Vanderriele, P.E., et al. (2019) PTH Mod-ulation by Aldosterone and Angiotensin II Is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy. The Jour-nal of Clinical Endocrinology & Metabolism, 104, 3726-3734. https://doi.org/10.1210/jc.2019-00143
|
[50]
|
Zavatta, G., Di Dalmazi, G., Altieri, P., et al. (2022) Association between Aldosterone and Parathyroid Hormone Levels in Pa-tients with Adrenocortical Tumors. Endocrine Practice, 28, 90-95.
https://doi.org/10.1016/j.eprac.2021.09.002
|
[51]
|
Latic, N. and Erben, R.G. (2022) Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System. Nutrients, 14, Article 5186.
https://doi.org/10.3390/nu14235186
|
[52]
|
Castellano, E., Pellegrino, M., Tardivo, V., et al. (2021) Aldosterone Se-cretion in Patients with Primary Hyperparathyroidism without Arterial Hypertension. Endocrine Practice, 27, 1072-1076.
https://doi.org/10.1016/j.eprac.2021.04.886
|
[53]
|
Parksook, W.W., Heydarpour, M., Brown, J.M., et al. (2023) Evaluating the Clinical and Mechanistic Effects of Eplerenone and Amiloride Monotherapy, and Combination Therapy with Cinacalcet, in Primary Hyperparathyroidism: A Placebo-Controlled Randomized Trial. Clinical Endocrinology, 98, 516-526. https://doi.org/10.1111/cen.14840
|
[54]
|
Rosenberg, J., Pines, M. and Hurwitz, S. (1987) Response of Adrenal Cells to Parathyroid Hormone Stimulation. Journal of Endocrinology, 112, 431-437. https://doi.org/10.1677/joe.0.1120431
|
[55]
|
Mazzocchi, G., Aragona, F., Malendowicz, L.K. and Nussdorfer, G.G. (2001) PTH and PTH-Related Peptide Enhance Steroid Secretion from Human Adrenocortical Cells. American Journal of Physiology-Endocrinology and Metabolism, 280, E209-E213. https://doi.org/10.1152/ajpendo.2001.280.2.E209
|
[56]
|
Helwig, J.J., Musso, M.J., Judes, C. and Nickols, G.A. (1991) Parathyroid Hormone and Calcium: Interactions in the Control of Renin Secretion in the Isolated, Nonfiltering Rat Kidney. Endocrinology, 129, 1233-1242.
https://doi.org/10.1210/endo-129-3-1233
|
[57]
|
Dobreva, E.A., Bibik, E.E., Eremkina, A.K., et al. (2020) Dynamic Changes of Renin-Angiotensin-Aldosterone System Parameters after Surgery of Primary Hyperparathyroidism. Tera-pevticheskii Arkhiv, 92, 63-69.
https://doi.org/10.26442/00403660.2020.10.000725
|